Page last updated: 2024-11-07

carbachol and Left Ventricular Dysfunction

carbachol has been researched along with Left Ventricular Dysfunction in 1 studies

Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.

Research Excerpts

ExcerptRelevanceReference
"However, it failed to affect left ventricular hypertrophy and even aggravated the impaired positive and negative lusitropic effects elicited by isoprenaline and carbachol, respectively."1.62Chronic cannabidiol treatment reduces the carbachol-induced coronary constriction and left ventricular cardiomyocyte width of the isolated hypertensive rat heart. ( Gajo, B; Harasim-Symbor, E; Kasacka, I; Malinowska, B; Pędzińska-Betiuk, A; Schlicker, E; Toczek, M; Weresa, J, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Pędzińska-Betiuk, A1
Weresa, J1
Schlicker, E1
Harasim-Symbor, E1
Toczek, M1
Kasacka, I1
Gajo, B1
Malinowska, B1

Other Studies

1 other study available for carbachol and Left Ventricular Dysfunction

ArticleYear
Chronic cannabidiol treatment reduces the carbachol-induced coronary constriction and left ventricular cardiomyocyte width of the isolated hypertensive rat heart.
    Toxicology and applied pharmacology, 2021, 01-15, Volume: 411

    Topics: Adrenergic beta-Agonists; Animals; Antihypertensive Agents; Cannabidiol; Carbachol; Cell Size; Coron

2021